Argenx
ARGX
$376.60
Share price
-0.10%
Change (1 day)
-7.15%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
Earnings for Argenx (ARGX)
Earnings in 2023 (TTM): -$0.31 B
According to Argenx 's latest financial reports the company's current earnings (TTM) are -$0.31 B. an increase over its 2022 earnings that were of -$0.73 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Argenx from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023  | -$0.31 B | -58.25% |
| 2022 | -$0.73 B | |
| 2019 | -$0.2 B | 124.97% |
| 2018 | -$88.43 M | 131.4% |
| 2017 | -$38.22 M | 55.11% |
| 2016 | -$24.64 M | 33.04% |
| 2015 | -$18.52 M | 13.63% |
| 2014 | -$16.3 M | 46.28% |
| 2013 | -$11.15 M |